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Regulation of Lymphokine Production and Human T Lymphocyte Activation
by 1,25-Dihydroxyvitamin D3
Specific Inhibition at the Level of Messenger RNA
William F. C. Rigby,** Sylvia Denome,t and Michael W. Fanger**
*Departments ofMedicine and tMicrobiology, Dartmouth Medical School, Hanover, New Hampshire 03756
Abstract
The steroid hormone, la,25-dihydroxyvitamin D3 (calcitriol),
has been shown to inhibit T cell proliferation, primarily through
inhibition of interleukin 2 (IL-2) production. In these experi-
ments, we show that calcitriol also markedly inhibited production
of the lymphokine, gamma interferon (IFN-y), by activated hu-
man T lymphocytes. Regulation of both IL-2 and IFN-y pro-
duction as well as transferrin receptor (TfR) expression by cal-
citriol was apparent at the messenger RNA (mRNA) level as
determined by Northern blotting. The decrease in IL-2 and IFN-
'y mRNA that occurred with calcitriol treatment was coordinate
and not apparent up to 12 h after phytohemagglutinin stimulation,
whereas decreased accumulation of TfR mRNA was not present
before 24-36 h. Furthermore, the effects of calcitriol on IL-2,
IFN-'y, and TfR mRNA accumulation were specific; actin mRNA
accumulation was comparable between control and treated cells.
These data indicate that calcitriol regulated proteins associated
with T cell activation at the transcriptional level and that these
effects were mediated in a specific, coordinate fashion.
Introduction
Recent studies have suggested that la,25-dihydroxyvitamin D3
(calcitriol) can modulate lymphocyte growth and function (1-
3). Awareness of this immunoregulatory activity of calcitriol
was prompted by studies of vitamin D metabolism as well as
the demonstration of specific receptors for vitamin D in mono-
cytes and activated lymphocytes (4, 5). Human pulmonary al-
veolar macrophages from patients suffering from sarcoidosis have
been shown capable of la-hydroxylation, which converts 25-
hydroxyvitamin D3 to calcitriol by a metabolic process distinct
in its regulation from classical renal metabolism of vitamin D
(6). Local production of calcitriol by macrophages may be suf-
ficient to cause systemic effects even in the absence of renal
production ofcalcitriol (7, 8). Moreover, normal human mono-
cytes and macrophages can be induced by gamma interferon
(IFN-7y)' or lipopolysaccharide (LPS) to exhibit I a-hydroxylase
activity (9). These findings, coupled with the discovery ofvitamin
D receptors in monocytes and activated, but not resting, T and
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1. Abbreviations used in this paper: IFN-y, gamma interferon; PBMC,
peripheral blood mononuclear cells; PHA, phytohemagglutinin; SSC,
saline plus 0.015 M sodium citrate, pH 7.0; TfR, transferrin receptors.
B cells suggested that calcitriol may be a macrophage-derived
product with immunomodulatory activity. Studies examining
this activity have revealed that calcitriol is a potent inhibitor of
T cell proliferation and immunoglobulin production (1-3). The
antiproliferative action ofcalcitriol specifically blocks transition
of T cells from early GI (GIA) to late GI (GIB) as well as their
acquisition oftransferrin receptors (TfR), and appears to be pri-
marily mediated through inhibition of interleukin 2 (IL-2) pro-
duction (1, 10). The ability of vitamin D metabolites to mediate
this activity correlates with the affinity with which they are bound
by vitamin D receptors (1-3). In the studies described in this
report, we present evidence that calcitriol has an additional pro-
found effect on immune reactivity by blocking IFN-'y production
by lectin-activated T cells. Furthermore, we have determined
that the induction of IL-2 and IFN-y production as well as TfR
expression that accompanies T cell activation is specifically in-
hibited by calcitriol at the level of mRNA.
Methods
Cellpreparation and culture. Peripheral blood mononuclear cells (PBMC)
from normal donors were isolated by Ficoll-Hypaque density centrifu-
gation, cultured at 2 X 106/ml in RPMI 1640 medium that was supple-
mented with 8% fetal calfserum (FCS) (both Hazelton Research Products,
Denver, PA), and stimulated with I ,ug/ml phytohemagglutinin (PHA)
(Wellcome Reagent Ltd., Beckenham, England) in the absence or pres-
ence of calcitriol (the generous gift of Dr. Milan Uskokovic, Hoffman-
LaRoche Inc., Nutley, NJ) or 25-hydroxyvitamin D3 (Upjohn Co., Kal-
amazoo, MI). Control cultures contained equivalent concentrations of
ethanol that never exceeded 0.01%. In RNA isolation experiments, PBMC
obtained by cytophoresis of normal volunteers were isolated and partially
depleted of monocytes by rotation in polypropylene tubes at 8 rpm for
I h at 4VC to induce monocyte clumping. This cell suspension was then
layered on ice cold FCS and clumped monocytes separated from lym-
phocytes by sedimentation for 20 min at 4VC. The lymphocytes obtained
were 70-80%o T3 positive as determined by flow cytometry. Cells were
cultured at 4 X 106/ml in RPMI 1640 with 8% FCS in the absence or
presence of 10 nM calcitriol and stimulated with I Ag/ml PHA alone or
in combination with 10 ng/ml phorbol myristic acetate (PMA) (Sigma
Chemical Co., St. Louis, MO).
Assay ofIFN-y production. Supernatants were harvested and clarified
through centrifugation at 10,000 gand were frozen at -20'C until shortly
before assay. Supernatants were analyzed for the level of IFN-'y by solid
phase radioimmunoassay (RIA) (Centocor Corp., Malvern, PA) that uti-
lized two murine monoclonal antibodies to different epitopes of biolog-
ically active IFN-'y. Antibody coupled to polystyrene beads was incubated
with culture supernatant, subsequently washed, and a second '25I-labeled
antibody was added to a different non-cross-reacting epitope of IFN-,y.
After washing, binding of the second antibody to beads was quantified
by using a gamma counter. Levels of IFN--y were then expressed as
reference units based on the values obtained with a standard that was
provided by the National Institutes of Health.
Measurement of IL-2, IFN--y, TJR, and actin mRNA levels. Total
RNA was extracted by a guanidinium isothiocyanate method with cesium
chloride gradient centrifugation (11). Poly(A)-RNA was selected by
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oligo(dT)-cellulose chromatography, then size fractionated by formal-
dehyde-agarose gel electrophoresis, transferred to a Biotrans nylon
membrane (ICN Radiochemicals, Div. ICN Biomedicals Inc., Irvine,
CA) in 20X saline plus 0.015 M sodium citrate, pH 7.0 (SSC), and
baked under vacuum at 80'C for 2 h. Filters were prehybridized overnight
at 42°C in 50% formamide, 0.8 M NaCl, 0.1 M PIPES, 0.1% Sarkosyl,
0.1I% Ficoll, 0.1% polyvinylpyrrolidone, 0.1% bovine serum albumin,
and salmon sperm DNA (200 ,g/ml). Hybridizations were performed
at 420C for 48 h in prehybridization mix that contained 10% dextran
sulfate and 1 X 106 cpm of 32P-labeled cDNA probes for IL-2 (12), IFN-
'y, or human actin (13) that had been nick-translated with 800 Ci/mmol
[32P]dCTP (Amersham Corp., Arlington Heights, IL) to a specific activity
of 1-2 X 108 dpm/,ug DNA. Filters were washed twice with 2X SSC that
contained 0.02% sodium pyrophosphate and 0.5% Sarkosyl at 20°C,
then washed four times with 0.1X SSC that contained 0.01% sodium
pyrophosphate and 0.5% Sarkosyl at 50°C. Blots were dried, and filters
exposed at -70°C to Kodak XAR film using one intensifying screen.
Sizes of mRNAs were estimated from the position of 28S (4.8 kilobase
[kb]) and 18S (2 kb) ribosomal RNA (rRNA) bands that were present
in the poly(A-RNA preparation. Similar data were observed in two other
experiments. For Northern blot analysis ofthe kinetics of calcitriol effect,
RNA was extracted at various time intervals (6-48 h after PHA stimu-
lation) from PBMC ofthree or four different donors. Total cellular RNA
was then pooled and poly(A)-RNA was isolated as described above.
Northern blotting and hybridization with 32P-labeled IL-2 complementary
DNA (cDNA) were performed as described above. After hybridization,
blots were stripped of 32P-labeled probe by two incubations at 85-90°C
for 20-min each in 0. IX SSC that contained 0.01% sodium pyrophosphate
and 0.05% Sarkosyl. Blots were subsequently stripped and hybridized
with 32P-labeled IFN-y, TfR, and actin cDNA probes.
Results
Effect ofvitamin D compounds on IFN-,y production. The lym-
phokine IFN-y is produced by activated T cells in response to
mitogen or antigen and has a broad range Qfimmunoregulatory
activity, including mapcrophage activation (14). Perhaps more
relevant has been the demonstration that IFN-'y can regulate
macrophage production of calcitriol (6, 9). Moreover, agents
that inhibit the production of IL-2 (glucocorticoids, cyclosporin
A) (15, 16) have been shown to also inhibit production of IFN-
-y (17, 18). We therefore examined the effect of calcitriol on
IFN-'y production by PBMC that were stimulated with PHA for
72 h (Table I). Calcitriol blocked IFN-'y production in a con-
centration-dependent fashion. Half-maximal suppression ofim-
munoreactive IFN-'y production was observed at calcitriol con-
centrations of 1 nM, with maximal effect apparent at 10 nM
calcitriol. The observed dose-resporse curve is similar to that
reported with inhibition of IL-2 production (1, 10). As found in
previous work, 25-hydroxyvitamin D3, which binds the vitamin
D receptors 100-fold less avidly than calcitriol (19), was without
detectable activity until much higher concentrations (1 mM).
These findings demonstrate the specificity ofthis activity of cal-
citriol and suggest that this inhibition is dependent on ligand
binding to vitamin D receptors. We have confirmed these results
through bioassay by utilizing the inhibition of viral cytopathic
effect on human fibroblasts by IFN-'y (data not shown).
Northern blot analysis ofthe effect ofcalcitriol on T cell ac-
tivation. To clarify the mechanism of action of calcitriol, we
examined its effect on the level of accumulation ofmRNA for
IL-2 and IFN-y at 20 h after PHA stimulation by using Northern
blotting (Fig. 1). In RNA from PHA-stimulated cells, we observed
a 1.0-kb RNA species that hybridized with the 32P-labeled full
length IL-2 cDNA probe, which was consistent with the size of
Table . Inhibition ofIFN-,y Production
by Vitamin D Compounds*
IFN-7
Treatment Donor I Donor 2 Donor 3
U/mi U/mi U/mi
Ethanol 888 1,070 1,070
1,25-(OH)2-D3 (10-'0M) 680 945 1,017
1,25-(OH)2-D3 (10-9M) 365 545 722
1,25-(OH)2-D3 (10-8M) 205 165 260
1,25-(OH)2-D3 (10-7M) 210 165 ND
25-OH-D3 (10-8M) 945 1,040 ND
25-OH-D3 (1Jt7M) 936 973 ND
25-OH-D3 (1Y6M) 175 127 ND
+ Inhibition of IFN-'y production by vitamin D compounds. Human
PBMC stimulated with PHA were cultured (2 X 106 cells/ml) for 72 h
in the absence or presence of varied concentrations of calcitriol (1,25-
[OH]2-D3), 25-hydroxyvitamin D3 (25-OH-D3), or ethanol. Superna-
tants were then assayed for IFN-y by RIA. Data shown represent the
average of duplicate samples with a maximum range of < 10% among
replicates.
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Figure 1. Northern blot analysis of IL-2 and IFN-'y mRNA from
PBMC activated in the absence or presence of calcitriol. 10 ,g/lane
poly(A)-RNA from PBMC that had been cultured at 4 X 10'/ml in
the absence or presence of 10 nM calcitriol for 20 h after activation
with PHA alone or in combination with 10 ng/ml PMA, were size-
fractionated and analyzed for the level of IL-2 and IFN--y mRNA by
using Northern blotting. Blots were overexposed to demonstrate larger
mRNA species.
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IL-2 mRNA previously reported (20, 21). The amount of IL-2
mRNA in poly(A)-RNA from calcitriol-treated PBMC was
markedly decreased relative to control. Treatment of cells with
PHA and PMA resulted in a significant increase in the level of
detectable IL-2 mRNA, as previously shown (22). Nevertheless,
calcitriol treatment caused a significant reduction in the level of
IL-2 mRNA, which suggests that the addition ofPMA to PHA
did not overcome the effects of calcitriol. This observation is
consistent with our previous finding that PMA addition to PHA
does not affect the antiproliferative activity of calcithiol (10).
Also, at least two species of larger mRNAs that hybridized with
the IL-2 probe were observed in poly(A)-RNA from cells acti-
vated with PHA and PBMC, which was consistent with the size
of precursor IL-2 mRNAs that have been previously reported
(21). The level of expression of each of these larger species of
IL-2 mRNA (perhaps representing precursors) was also reduced
by calcitriol treatment.
In companion experiments, a similar pattern of reduction
in IFN-'y mRNA accumulation by calcitriol was observed (Fig.
1). Northern blotting with a 32P-labeled IFN-'y cDNA and IFN-
y-L8-9 that contained - 75% ofthe coding sequence ofmature
IFN-y revealed a 1.4-kb band in poly(A)-selected RNA from
PHA-stimulated cultures that was augmented by the addition
ofPMA. Under both sets of conditions (PHA without and with
PMA), calcitriol treatment ofcells reduced the levels ofdetectable
IFN-y mRNA. In addition, two bands of larger mRNA (I 4.4
and 5.2 kb) that hybridized with 32P-labeled IFN-'y cDNA were
observed in each experiment, and also apparently increased in
response to PMA treatment. Calcitriol treatment reduced the
level of expression of these larger mRNA species as well. These
data demonstrate that accumulation ofboth mature and possibly
precursor forms of IL-2 and IFN-'y mRNA were reduced by
calcitriol treatment.
To determine if IL-2 is necessary for IFN-y production (23,
24) or if there is coordinate regulation ofthe expression ofthese
genes (25, 26), we examined the kinetics ofthe effect of calcitriol
on the levels ofIL-2 and IFN-'y mRNA in lectin-stimulated cells
(Figs. 2 and 3). In this experiment, the level of IL-2 mRNA
accumulation was observed to be maximal at 6 h. The level of
IL-2 mRNA decreased at 12 h, and slightly increased at 24 h.
Calcitriol treatment did not affect the level df accumulation of
IL-2 mRNA until 24 h, at which point a progressive reduction
in IL-2 mRNA relative to controls was observed. Interestingly,
at 6 h, calcitriol slightly but consistently augmented the level of
IL-2 mRNA relative to controls, while at 12 h equivalent levels
ofIL-2 mRNA were observed. Similarly, no significant inhibitory
effect of calcitriol on IFN-y mRNA accumulation was observed
before 24 h, after which calcitriol caused a progressive reduction
in the levels of IFN-y mRNA. As found with IL-2 mRNA, cal-
citriol treatment appeared to effect a slight increase in the level
of IFN-'y mRNA relative to controls at 6 h, whereas a slight
decrease in IFN-'y mRNA first became apparent at 12 h. In a
second experiment (Fig. 4), this biphasic pattern of induction
of IL-2 and IFN-,y was more evident, with decreased IL-2 and
IFN-'y mRNA accumulation at 12 h relative to that seen at 6
and 24 h. Nevertheless, in each experiment, the inhibition of
IL-2 and IFN-y mRNA accumulation observed with calcitriol
treatment was not apparent until 12-24 h.
Induction of TfR gene transcription by T lymphocytes has
been shown to follow that of IL-2 and IFN-'y (25), and has been
demonstrated to be dependent on IL-2 interacting with its re-
ceptor (27). In previous work we have observed that calcitriol
hrs. 6 12 24 36 48
IL-2
IFN-Y * a
ACTIN -
TfR _
Figure 2. Northern blot analysis of the kinetics of IL-2, IFN-y, and
TfR mRNA induction and its inhibition by calcitriol. PBMC from
three donors were cultured in the absence (-) or presence (+) of calci-
triol (10 nM), and RNA was extracted at various time intervals (6-48
h after PHA addition). Total cellular RNA for each time point and
treatment was pooled and poly(A)-RNA was isolated by oligo(dT)-cel-
lulose chromatography. Northern blotting (5 ,g poly[A]-RNA/lane)
and hybridization with 32P-labeled IL-2 cDNA were performed as de-
scribed in Fig. 1. After hybridization and autoradiography with IL-2
cDNA, blots were stripped and subsequently rehybridized with 32P-la-
beled IFN-y, TfR, and actin cDNA probes. Blots were overexposed
for sake of photography.
inhibited TfR expression on activated T cells, whereas IL-2 re-
ceptors were unaffected (10). We therefore examined the effect
of calcitriol on the kinetics of TfR mRNA accumulation in ac-
tivated T cells by using the TfR cDNA pcD-TRl (Figs. 2-4)
(28). We observed that peak TfR mRNA accumulation occurred
much later than with IL-2 or IFN-'y (24-36 h after PHA stim-
ulation). No reduction in TfR mRNA accumulation by calcitriol
was observed before 24 h, with inhibition becoming marked by
LUJ
C,,
LUJ
-J
LU
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162
°6 12
IL-2
24 36 48
TIME (H)
Figure 3. Time course of IL-2,
IFN--y, TfR, and actin mRNA ac-
cumulation and its inhibition by
calcitriol. Autoradiograms demon-
strated in Fig. 2 were quantified by
densitometry, and relative absor-
bance was plotted as a function of
time. Decreased exposures of the
IL-2 and IFN-'y blots shown in
Fig. 2 were utilized for densitome-
try. Open symbols (o, A) represent
values obtained with ethanol con-
trols; closed symbols (e, A) repre-
sent calcitriol treatment. In the
middle panel, IFN-'y and TfR
mRNA accumulation are repre-
sented by triangles and circles, re-
spectively.
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hrs. 6 12 24 36 48 to decreased RNA transcription, or increased degradation ofIL-
- + - + - + - + - + 2 or IFN-y mRNA, has not been established. Studies of the
* m _ ,effect of calcitriol treatment on nuclear transcription and message
-2- d 111 * w * * id stability will help address these issues.
In contrast to glucocorticoids (15), resting T cells do not
express a receptor for calcitriol unless activated (4, 5). Consistent
-r- * * * * * * with this observation, calcitriol did not inhibit the initial increase
in cellular RNA that accompanies early T cell activation (Go-
G1A transition) (10). Rather, calcitriol appeared to specifically
inhibit GlA-GlB transition and the acquisition of TfR, both of
R 0 0 lIP * I, _m a which have been shown to be IL-2-dependent events (27-29).fR 404 1
Our findings here illustrate that calcitriol does not significantly
e 4. Northern blot analysis of the kinetics of IL-2, IFN-,y, and reduce the level of IL-2 or IFN-y mRNAs for at least the first
nRNA induction and its inhibition by calcitriol. PBMC from 6-12 h, whereas TfR mRNA accumulation is not inhibited for
lonors were cultured and poly(A)RNA isolated as described in the first 24 h. These observations are consistent with the possi-
Northern blotting (7 gg poly[AJ-RNA/lane except at 48 h bility that until vitamin D receptors are induced in T cells, cal-
4 pig/lane was used) and hybridizations with IL-2, IFN-', and citriol cannot effect any changes in the level of expression of
were performed as described in Fig. 2. these products ofT cell activation. Alternatively, vitamin D re-
ceptors may be induced quite early (< 6 h) in T cell activation,
in these two experiments. Interestingly, at earlier times (6- but the process that regulates the level of IL-2, IFN-y, and TfR
in each experiment, it appeared that calcitriol augmented mRNA expression may only become sensitive to the inhibitory
Accumulation of TfR mRNA relative to controls. Though action of calcitriol after 6-12 h. Either possibility is consistent
ar to observations with IL-2 and IFN-7 mRNA, the increase with our findings that calcitriol blunts, but does not totally ab-
R mRNA accumulation in calcitriol-treated cells relative rogate, the production of these lymphokines or the expression
ntrol cells seen at 6-12 h (Figs. 2 and 3) and 24 h (Fig. 4) of TfU by activated T lymphocytes.
nore apparent. The slightly different rates at which the effect The rapid (6 h) induction of most of IL-2 mRNA by PHA
Icitriol is noted may be due to donor variation, as different seen in our first experiment is consistent with that previously
f donors were used in each experiment. Finally, the selec- reported using either the Jurkat cell line orPBMC (21, 30). This
of this activity of calcitriol was demonstrated by the finding is in contrast to the levels of IL-2 mRNA as measured by Xe-
despite a significant reduction in the level of IL-2, IFN-'y, nopus laevis oocyte assay, where peak levels of IL-2 production
TfR mRNAs with calcitriol treatment, comparable levels were found with mRNA that was obtained 20 h after lectin stim-
tin mRNA were observed throughout (Figs. 2 and 3). ulation (26, 31). These different observations may result from
different assay techniques: levels of IL-2 mRNA measured by
bussion hybridization of a cDNA probe may not accurately reflect the
utility of this IL-2 mRNA in a Xenopus oocyte translation sys-
is paper, we examined the immunomodulating activity of tem. Another possibility is suggested by our observation that IL,
triol at both the cellular and molecular level. IL-2 and IFN- 2 mRNA expression appears to initially decline at 12 h in each
)duction have been shown to accompany T cell activation. experiment followed by an increased accumulation at 24 h. It
ave found that calcitriol inhibits IFN-y production by PHA- may be that a second peak in IL-2 mRNA expression occurs
ilated T cells with a concentration-dependence similar to between 12 and 24 h. Such a finding would be consistent with
)bserved with IL-2 (1-3). Furthermore, we found that cal- the observation that T cell activation occurs in an asynchronous
1 reduces the level of accumulation of both IL-2 and IFN- fashion (32). Thus, in a heterogeneous population of T cells
RNA 20 h after stimulation. Time course studies of IL-2 stimulated with lectin, different T cells might be activated to
FN--y mRNA accumulation after T lymphocyte stimulation express IL-2 mRNA at different times. The demonstration that
omparable, which suggests coordinate regulation of their calcitriol inhibits IL-2 and IFN-'y mRNA at 20-24 h could pos-
ssion. Moreover, the time course of the reduction by cal- sibly reflect the sensitivity to vitamin D of T cells that are ac-
1 of IL-2 and IFN-'y mRNA levels was similar. These data tivated later. It is unlikely, however, that differential rates of
fore suggest that the reduction in IFN-y mRNA accumu- activation of CD4+ and CD8+ T cells could account for these
i by calcitriol is not due to decreased IL-2 production. effects, since we have observed equivalent sensitivity and kinetics
er, the decreased levels ofIL-2 and IFN-'y mRNA expression ofeach of these T cell subsets to the antiproliferative activity of
-ed by calcitriol treatment may be mediated through a corm- calcitriol (33).
pathway. In addition, consistent with our earlier observa- Not accounted for by these hypotheses is the slight but con-
on IL-2 production (4), no significant reduction in either sistent and specific increase in mRNA for IL-2 and IFN-'y we
or IFN-,y mRNA is seen with calcitriol treatment in the observe at 6 h with calcitriol treatment relative to controls. Sim-
i2 h after lectin stimulation. ilar, more dramatic augmentation ofmRNA accumulation with
hese findings demonstrate that calcitriol, like cyclosporin calcitriol treatment was observed with TfR in each experiment
d glucocorticoids, can specifically regulate the production before any inhibition was observed. Calcitriol may induce this
th IFN-'y and IL-2 and that these effects are apparent at biphasic response directly on the T cell, first stimulating initial
*vel of the mRNAs that specifically encode these proteins. T cell activation, followed by a specific inhibition of IL-2, IFN-
e effects appear to be relatively specific, with both levels of oy, and TfR mRNA accumulation. Alternatively, this early aug-
mRNA and Tac antigen expression (10) not significantly mentation of IL-2, IFN-'y, and TfR mRNA accumulation may
Led by calcitriol treatment. Whether these changes are due be mediated through the effect of vitamin D compounds on
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accessory cell function. Interleukin 1 (IL-1) production by ac-
cessory cells has been shown to be important in T cell activation
(34-36). Calcitriol has been found to augment IL-I production
by monocytes (36), perhaps resulting in more rapid, efficient T
cell activation. Increases in cytoplasmic-free calcium have been
implicated in both initial T cell activation (37, 38) as well as IL-
1 production by monocytes (39). Recent work has demonstrated
that calcitriol can induce rapid increases in cytoplasmic-free cal-
cium (40), which suggests a mechanism that could account for
either of these activities. Since induction of TfR expression on
T cells is dependent on an interaction of IL-2 with its receptor
(27), the augmentation in TfR mRNA observed with calcitriol
at 6 and 12 h may be a consequence of increased IL-2 message
and subsequent IL-2 production. Alternatively, calcitriol could
directly effect this biphasic response on all the genes involved
in T cell activation that are susceptible to its action.
These data demonstrate the specificity of calcitriol in mod-
ulating T cell activation and proliferation as well as lymphokine
production. The conversion by monocytes and macrophages of
25-hydroxyvitamin D3 into calcitriol may therefore represent a
negative feedback loop on T cell proliferation and IFN-'y pro-
duction. Once adequate levels of macrophage activation are
achieved, local production of calcitriol may regulate T lympho-
cyte-driven immune reactivity and inflammation. Calcitriol may
thus be unique as a steroid hormone produced both by and for
cells of the immune system.
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